title: 2016 New Drug Update.
abstract: Six new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include a hypnotic, an anticoagulant, two drugs for heart failure, and two drugs to reduce low-density lipoprotein cholesterol.
authors.affiliation: Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D017277:Drug Approval; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D014481:United States
chemical_list: D000924:Anticholesteremic Agents; D000925:Anticoagulants; D006993:Hypnotics and Sedatives